Skip to main navigation Skip to search Skip to main content

A Phase 2/3 Double-Blind, Randomized, Placebo-Controlled Adaptive Design Trial to Evaluate the Efficacy and Safety of Intravenous ACU193 in Early Alzheimer¿s Disease

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date11/18/24 → 11/17/25

Funding

  • Acumen Pharmaceuticals Incorporated: $18,500.00